Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Up 127.4% in February

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFFGet Free Report) saw a significant increase in short interest in February. As of February 28th, there was short interest totalling 48,900 shares, an increase of 127.4% from the February 13th total of 21,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Shares of LABFF remained flat at C$65.86 during midday trading on Friday. The firm’s fifty day simple moving average is C$65.86 and its 200 day simple moving average is C$77.03. Laboratorios Farmaceuticos Rovi has a 1 year low of C$65.86 and a 1 year high of C$65.86.

About Laboratorios Farmaceuticos Rovi

(Get Free Report)

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.

See Also

Receive News & Ratings for Laboratorios Farmaceuticos Rovi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and related companies with MarketBeat.com's FREE daily email newsletter.